| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2009 | 2020 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.400 | None | 0.933 | 2 | 0 | 2002 | 2019 | ||||||||
|
C-C motif chemokine ligand 11 | 0.473 | 0.885 | 1.0E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
C-C motif chemokine ligand 1 | 0.587 | 0.692 | 8.0E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 9 | 0.462 | 0.808 | 2.9E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
C-C motif chemokine ligand 22 | 0.500 | 0.846 | 8.4E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 13 | 0.472 | 0.731 | 0.83 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.498 | 0.808 | 5.0E-08 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2018 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 0 | 2011 | 2017 | ||||||||
|
phospholipase A2 group IIA | 0.488 | 0.808 | 9.7E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2015 | 2016 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
nuclear receptor subfamily 4 group A member 1 | 0.490 | 0.731 | 0.37 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2015 | ||||||||
|
ATP binding cassette subfamily C member 4 | 0.536 | 0.769 | 1.1E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 1999 | 2015 | ||||||||
|
prostaglandin F receptor | 0.705 | 0.423 | 6.6E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
steroid 5 alpha-reductase 1 | 0.631 | 0.538 | 1.2E-05 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
histone deacetylase 1 | 0.460 | 0.846 | 0.61 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2013 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
succinate-CoA ligase GDP-forming subunit beta | 0.780 | 0.308 | 5.7E-14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
histone deacetylase 2 | 0.476 | 0.846 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
nuclear receptor subfamily 3 group C member 2 | 0.469 | 0.846 | 0.84 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 |